The FLNC Gene Myopathy Distal Type 4 Genetic Test is a specialized diagnostic tool designed to identify mutations in the FLNC gene, which are associated with Distal Myopathy Type 4. This condition is a rare genetic disorder characterized by muscle weakness and atrophy, primarily affecting the lower limbs and, in some cases, progressing to involve upper limbs and other muscle groups. The FLNC gene plays a crucial role in muscle function and stability, and mutations in this gene can disrupt normal muscle architecture, leading to the symptoms observed in affected individuals.
Conducted at DNA Labs UAE, a leading facility in genetic diagnostics, this test involves analyzing the patient's DNA to detect abnormalities in the FLNC gene that could indicate the presence of Distal Myopathy Type 4. The process is meticulous, ensuring high accuracy and reliability in the results.
The cost of the FLNC Gene Myopathy Distal Type 4 Genetic Test is set at 4400 AED. While the price may seem significant, it reflects the advanced technology and expertise required to perform such specialized genetic testing. For patients and families affected by this condition, the test offers invaluable information for confirming the diagnosis, understanding the risk of passing the condition to offspring, and making informed decisions about management and treatment options.
DNA Labs UAE is known for its commitment to providing comprehensive and confidential genetic testing services, making it a trusted choice for individuals seeking answers to complex genetic questions.
The "DYSF Gene Myopathy Distal with Anterior Tibial Onset Genetic Test" is a specialized diagnostic assessment designed to identify mutations in the DYSF gene, which are implicated in a rare form of muscular dystrophy known as Dysferlinopathy. This condition is characterized by muscle weakness and atrophy, initially affecting the anterior tibial muscles in the legs, and can progressively involve other muscle groups. The test is crucial for confirming the diagnosis, understanding the disease progression, and guiding treatment options.
Performed at DNA Labs UAE, the test involves analyzing the patient's DNA to detect specific genetic alterations in the DYSF gene. The process requires a sample of the patient's blood or saliva, from which DNA is extracted and examined for the presence of mutations associated with the condition.
The cost of the test is set at 4400 AED, reflecting the comprehensive nature of the genetic analysis and the specialized expertise required to interpret the results. By providing a definitive diagnosis, this test plays a vital role in the management of patients with symptoms suggestive of Dysferlinopathy, enabling targeted interventions and genetic counseling for affected individuals and their families.
The "TTN Gene Myopathy Early-Onset with Fatal Cardiomyopathy Genetic Test" is a specialized diagnostic tool offered by DNA Labs UAE, designed to identify mutations in the TTN gene. These mutations are associated with early-onset myopathy, a condition characterized by muscle weakness and wasting, which can lead to severe, often fatal, cardiomyopathy - a disease of the heart muscle that makes it harder for the heart to pump blood to the rest of the body.
This genetic test is crucial for individuals who exhibit symptoms of myopathy or have a family history of cardiomyopathy, as early detection can significantly influence management and treatment options. The test involves analyzing the patient's DNA to look for specific genetic alterations in the TTN gene, which is known to play a vital role in muscle function and structure.
Priced at 4400 AED, the test is conducted in the state-of-the-art facilities of DNA Labs UAE, ensuring accuracy and reliability of the results. By opting for this test, patients and their families can gain valuable insights into their genetic predisposition to these conditions, enabling them to make informed decisions regarding their health and future.
The "YARS2 Gene Myopathy Lactic Acidosis and Sideroblastic Anemia Type 2 Genetic Test" is a specialized diagnostic assessment offered by DNA Labs UAE, designed to detect mutations in the YARS2 gene. These mutations are responsible for a rare but severe condition that combines features of myopathy, lactic acidosis, and sideroblastic anemia. Myopathy affects muscle fibers, lactic acidosis involves an excess of lactic acid in the body, and sideroblastic anemia is a disorder where the bone marrow produces ringed sideroblasts rather than healthy red blood cells. The accurate identification of mutations in the YARS2 gene through this test is crucial for the diagnosis, management, and understanding of the patient's condition. The test is priced at 4400 AED, reflecting the sophisticated technology and expertise required to perform this genetic analysis. Conducted at DNA Labs UAE, this test represents an important tool in the diagnosis and treatment planning for patients affected by these complex, interconnected conditions.
The GFER Gene Myopathy Mitochondrial Progressive with Congenital Cataract, Hearing Loss, and Developmental Delay Genetic Test is a specialized diagnostic examination offered by DNA Labs UAE, designed to identify mutations in the GFER gene. These mutations are associated with a rare, inherited disorder that affects mitochondrial function, leading to a spectrum of symptoms including progressive myopathy (muscle weakness), congenital cataracts, hearing loss, and developmental delays in affected individuals.
The test involves collecting a DNA sample, typically through a blood draw or cheek swab, which is then analyzed in the laboratory to detect any genetic abnormalities in the GFER gene. This precise genetic testing is crucial for confirming the diagnosis, understanding the condition's progression, and guiding treatment options for patients and their families.
The cost of the GFER Gene Myopathy Mitochondrial Progressive with Congenital Cataract, Hearing Loss, and Developmental Delay Genetic Test at DNA Labs UAE is 4400 AED. This investment includes the comprehensive analysis necessary to achieve accurate results, providing essential information for managing the condition effectively.
MT-TQ Gene Myopathy is a rare genetic condition that affects muscle function and strength, leading to various degrees of muscle weakness and other symptoms. The condition is caused by mutations in the MT-TQ gene, which is involved in mitochondrial function. Mitochondria are crucial for energy production in cells, and mutations in mitochondrial genes can lead to a range of metabolic and muscular disorders, including MT-TQ gene myopathy.
To diagnose this condition, genetic testing is essential. In the United Arab Emirates, DNA Labs UAE offers a specialized genetic test aimed at identifying mutations in the MT-TQ gene. This test is a critical tool for confirming the diagnosis of MT-TQ gene myopathy, allowing for appropriate management and treatment plans to be established for affected individuals.
The cost of the MT-TQ related genetic test at DNA Labs UAE is 4400 AED. This test is performed under stringent laboratory conditions by experienced professionals, ensuring accurate and reliable results. The investment in this test is crucial for families seeking answers to unexplained muscle weakness and related symptoms, paving the way for a better understanding of the condition and potential treatment options.
The "DES Gene Myopathy Myofibrillar Desmin Related Genetic Test" is a specialized diagnostic procedure offered by DNA Labs UAE, aimed at detecting mutations in the DES gene. These mutations are associated with a group of conditions known as desmin-related myopathies (DRM), which are characterized by the abnormal aggregation of desmin protein in muscle cells, leading to muscle weakness and atrophy. The test plays a crucial role in the accurate diagnosis and management of patients with symptoms suggestive of DRM, enabling healthcare professionals to tailor treatment plans effectively.
Performed using a blood sample, this genetic test focuses on analyzing the DES gene to identify any alterations that might contribute to the development of myofibrillar myopathies. It is particularly valuable for individuals presenting with muscle weakness, cardiac abnormalities, or family history of similar symptoms, offering insights into the genetic underpinnings of their condition.
DNA Labs UAE, a leading provider of genetic testing services in the region, offers this test at a cost of 4400 AED. The price reflects the sophisticated technology and expertise required to accurately detect and interpret DES gene mutations. By opting for this test at DNA Labs UAE, patients and their families can expect comprehensive support, from sample collection to result interpretation, aiding in the pursuit of a definitive diagnosis and informed approach to management and therapy.
The "CRYAB Gene Myopathy Myofibrillar Fatal Infantile Hypertrophy Alpha-B Crystallin-Related Genetic Test" is a specialized diagnostic tool offered by DNA Labs UAE, designed to identify mutations in the CRYAB gene, which are linked to a rare and severe form of myopathy. This condition is characterized by myofibrillar disintegration, fatal infantile hypertrophy, and is associated with the alpha-B crystallin protein. The test plays a crucial role in diagnosing this genetic disorder, enabling healthcare professionals to understand the specific genetic mutation present, which can significantly impact treatment plans and patient management. The cost of the test is 4400 AED, reflecting the intricate technology and expertise required to accurately identify mutations in the CRYAB gene and provide essential information for families and medical providers dealing with this challenging condition.
The LDB3 Gene Myopathy Myofibrillar ZASP Related Genetic Test is a specialized diagnostic tool offered by DNA Labs UAE, designed to identify mutations in the LDB3 gene, which are associated with myofibrillar myopathy. This condition is characterized by muscle weakness and atrophy, alongside the disintegration of myofibrils, which are crucial components of muscle fibers. The LDB3 gene, also known as ZASP, plays a significant role in maintaining the structural integrity of muscle cells. Mutations in this gene can lead to various forms of myopathy, making this test an essential tool for accurate diagnosis and management of the condition.
Priced at 4400 AED, the test involves analyzing the patient's DNA to detect any genetic alterations in the LDB3 gene that may be responsible for the myofibrillar myopathy. This genetic test is particularly valuable for individuals experiencing symptoms of myopathy, or those with a family history of the condition, as it can provide a definitive diagnosis, guide treatment options, and help in understanding the risk of passing the condition on to future generations. Conducted in the advanced facilities of DNA Labs UAE, the test ensures high accuracy and reliability, offering crucial insights for patients and healthcare providers in managing myofibrillar myopathies.
The "STIM1 Gene Myopathy Tubular Aggregate Type 1 Genetic Test" is a specialized diagnostic examination conducted to identify mutations in the STIM1 gene, which are associated with a rare condition known as Tubular Aggregate Myopathy Type 1. This condition is characterized by muscle weakness and fatigue, with tubular aggregates found in muscle cells upon biopsy, which are indicative of abnormal calcium regulation. The STIM1 gene plays a crucial role in calcium signaling within cells, and mutations can disrupt this process, leading to the symptoms observed in affected individuals.
The test is performed at DNA Labs UAE, a reputable facility known for its advanced genetic testing services. With a cost of 3200 AED, the test offers a comprehensive analysis of the STIM1 gene to confirm a diagnosis, enabling targeted management and treatment strategies for patients. It is particularly valuable for individuals showing symptoms of muscle weakness or those with a family history of Tubular Aggregate Myopathy, providing crucial insights into their condition and guiding healthcare decisions.
